抑制CDK9可以抑制前列腺癌中的多种瘤转录和表观遗传途径
Razia Rahman1, Muhammed H Rahaman2, Adrienne R Hanson1
1Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Bedford Park, SA, Australia.
British journal of cancer
|August 8, 2024
概括
像CDKI-73这样的循环素依赖性激酶9 (CDK9) 抑制剂通过破坏关键癌症通路来治疗前列腺癌具有前景. 与BRD4抑制剂的联合治疗可能会提高疗效,特别是在耐药病例中.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 循环素依赖性激酶9 (CDK9) 在激活各种癌症中的瘤转录途径方面发挥着至关重要的作用.
- CDK9抑制剂代表了癌症治疗开发的重大进展.
- 前列腺癌,特别是攻击性亚型,需要新的治疗策略.
研究的目的:
- 在前列腺癌的临床前模型中评估口服生物可用的CDK9抑制剂CDKI-73的疗效.
- 阐明CDKI-73抗癌作用背后的分子机制.
- 探索涉及CDKI-73的组合疗法,以提高治疗结果.
主要方法:
- 使用前列腺癌细胞系,异种移植模型和患者衍生器官的体外和体内研究.
- 通过公开数据集和免疫组织化学评估临床样本中的CDK9表达.
- 分子分析,包括转录组和表观组分析,以了解CDKI-73对细胞通路的影响.
主要成果:
- CDKI-73在雌激素受体 (AR) 驱动的和AR独立的前列腺癌模型中显示出显著的增殖抑制和细胞死亡诱导.
- CDKI-73抑制了RNA聚合酶II活性,导致抗亡因子BCL-2的表达减少和其他转录缺陷.
- CDKI-73重新编程了超级增强剂,并抑制了涉及AR,MYC和BRD4的关键致癌途径.
- 结合CDKI-73与BRD4抑制剂 (AZD5153) 在患者衍生器官和体内模型中显示出协同效应.
结论:
- 抑制CDK9有效地破坏了对前列腺癌进展至关重要的多种瘤转录途径.
- CDKI-73作为单一药物和前列腺癌组合疗法具有显著的治疗潜力.
- 特别是CDKI-73对于治疗侵袭性和耐治疗性前列腺癌的治疗具有前景.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
10.3K
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
02:39Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K